ICMR - NIRBI


ICMR - National Institute for Research
in Bacterial Infections

आईसीएमआर - राष्ट्रीय जीवाणु संक्रमण अनुसंधान संस्थान

Department of Health Research, Ministry of Health and Family Welfare, Government of India
स्वास्थ्य अनुसंधान विभाग, स्वास्थ्य और परिवार कल्याण मंत्रालय, भारत सरकार
WHO Collaborating Centre For Research and Training On Diarrhoeal Diseases

BETI BACHAO BETI PADHAO
G20

  English   |   हिंदी           

NICED : Scientists

  1. NICED
  2. Scientists
Dr. Mamta Chawla Sarkar

Dr. Mamta Chawla Sarkar

Dr. Mamta Chawla-Sarkar joined ICMR-NICED, Kolkata in January 2006 as Scientist C. She gained her Master's in Zoology in 1992 from Calcutta University and acquired the degree of Ph.D from Bose Institute-Jadavpur University, Kolkata in 1999. She did her Post-doctoral research work as Research Associate for six years in the Center for drug discovery & development, Taussig Cancer Center, Cleveland Clinic Foundation, Cleveland. Her research focus was analysis of the genes involved in anti-canter effects of Interferons and the mechanisms underlying IFN resistance in tumors of different histopathologies. Dr Chawla-Sarkar was promoted as Scientist F in 2019.

After joining ICMR-NICED, Dr. Chawla-Sarkar initiated studies both basic and Public health aspects of RNA viruses which cause significant morbidity and mortality worldwide. As part of a National Diarrhoeal disease research institute, her focus is on enteric viruses. An estimated 200,000 deaths are attributable to rotavirus each year, over 20% of which are estimated to occur in India. Inspite of their great medical importance, information about the molecular mechanism by which these subvert their hosts' cellular immune response or the involvement of host proteins during infection was not well defined. Her studies using OMICS platforms (microarray and proteomics) have led for first time to the identification of a number of cellular genes which positively aid virus replication. The host proteins are either upregulated, downregulated or modified post translationally by the viral proteins. Modulation of a subset of cellular genes by using agonists or antogonists have shown potent anti-viral effects with minimum cytotoxic effects on the cells suggesting that Host-targeted antivirals can be exploited as potential antiviral therapeutics. She has extended her experience on Rotavirus to SARS-CoV2 in 2021 and is currently focusing on role of lncRNA's in SARS-CoV2 infection and pathogenesis.

Besides this, she has made vital contributions towards viral disease surveillance. Her lab was the nodal lab for Influenza virus testing in the eastern India. During the Influenza A/H1N1/2009 pandemic and H1N1outbreaks since 2009, her lab provided the full laboratory diagnostic service to the WB State health department. In addition, her lab also served as east-zone referral lab for the National Rotavirus Surveillance Network. During the COVID -19 pandemic, Dr Chawla Sarkar was part of the team which led to providing lab diagnosis, kit validation, full genome sequencing and phylogenetic analysis of SARS Cov2 strains.

Human Resource development and capacity building has also been given importance- As of 2022, 15 students have been awarded Ph.D.; six students are working for their Ph.D. She has provided hand on training to the MSc students, technicians and microbiologists for handling of clinical samples, ELISA/ PCR based diagnosis of viruses.
Dr. Chawla- Sarkar has published > 95 research papers in peer reviewed journals. She received NASI fellowship (FNASc) in 2013, DBT's Women Scientist (Young) award (2013), ICMR's Kanishka Oration award (2017), Fellowship of WB Academy of Science and Technology (2018), Fellowship of INSA (FNA) in 2020 for her scientific contributions in field of viral diseases.
 

General Information
Name Dr. Mamta Chawla Sarkar
Designation Scientist G
Date of joining ICMR 09th January 2006
Date of joining present post: 01 July 2025
Discipline:  Molecular Virology/ Host Pathogen interaction
Division Virology
Specialization Virology, Molecular Biology
Email : chawlam70@gmail.com
Academic Qualification  
Graduation: BSc. Zoology (Hons), Calcutta University
Post Graduation : MSc. Zoology, Calcutta University
Doctoral Microbiology/Life Sciences, Jadavpur University
   

Profile

Research Experience

Dr. Mamta Chawla-Sarkar has more than 20 years of research experience in the field of biomedical research. During her post-doctoral training (1999-2005) at Cleveland Clinic Foundation, USA, she worked on understanding the role of IFN as anti-cancer therapeutics and mechanisms which underlie IFN resistance in subset of patients. In 2006, she joined as Scientist C in ICMR-NICED and started studying both basic and public health aspects of Rotavirus (Enteric) and Influenza A virus (Respiratory), both of which cause significant morbidity worldwide. Her research group focus involved strain surveillance, host-virus interaction and identifying cellular proteins/miRNAs involved in viral pathogenesis for developing potential antiviral targets. She coordinated ICMRs National Rotavirus Surveillance Network and Influenza Surveillance Network in the Eastern zone. Dr. Chawla-Sarkars lab was responsible for providing laboratory support in West Bengal during A/H1N1 pandemic in 2009 and during the SARS-CoV2 pandemic in 2020-21. In addition, her team performed sequence analysis and phylogenetic analysis of the SARS-CoV2 strainsand performed molecular kit validations. She has been actively involved in institutional activities related to Biosafety, promotion of Rajbhasha and preparing technical specifications for equipment purchase.

Research Interests

Research Interests of Dr. Chawla Sarkar and her team involve studies on both basic and public health aspects of infectious pathogens. Following broad areas of research are:

  1. Molecular epidemiology and strain surveillance of enteric viruses and respiratory viruses: Lab contributes data in the national portal of VRDL network
  2. Technology Development: Developing and validation of low cost, sensitive molecular diagnostic assays for detection of infectious pathogens
  3. Host pathogen Interaction studies using OMICs platform for identifying crucial host determinants of infection and pathogenesis: The study aims to identify host targets for developing therapeutics and or biomarkers as prognostic markers for disease severity. Screening (in vitro and preclinical small animal model) of small molecules/ phytochemicals targeting the host determinants against viral/bacterial pathogens of public health importance.

Membership/ Fellow of Professional Societies/ Associations

  1.  Fellow of the Indian National Science Academy ( FNA) 2020
  2. Fellow of the National Academy of Science in India (FNASc) in 2013
  3. Fellow of the West Bengal Academy of Science and Technology (FWAST) 2018
  4. Fellow of the Indian Virological Society (IVS)2020
  5. Member of Indian Science Congress Association
  6. Member of the Society of Biological Chemists
  7. Member of the Indian Virological Society

Awards

  1. DBT's National Women Bioscientist Award (Young Category) in 2013
  2. ICMR Kshanika Oration Award 2017

Projects

Extramural

  1. Multisite Monitoring of Influenza virus strains Surveillance in India Phase II ( ICMR/CDC USA) :2009-2014 (5years)
  2. Analysis of rotaviruses and their interactions with the host: A Viral Proteomics Approach ( Okayama University/AMED, Japan): 2010-2015 (5years)
  3. Establishment of a network of Laboratories for managing epidemics and Natural Calamities VRDL network ( DHR-ICMR) 2015- onwards ( 10 years)
  4. National Rotavirus Surveillance Network - Referral Lab Eastern India (ICMR) : 2013-2016 (4year)
  5. Screening of small molecules with antiviral activity as adjunct therapy for viral diarrhea( Okayama University/AMED, Japan): 2015-2018 ( 3 years)
  6. An approach to identify the environmental drivers modulating rotavirus seasonality (ICMR): 2017-2020 (3years)
  7. Study of regulation of RNA interference during Rotavirus infection and characterization of cellular miRNAs as novel antiviral therapeutics ( DST-SERB): 2018-2021 ( 3 Years)
  8. Coupling virus-host interactomics to host subcellular quantitative proteomics: An unbiased integrated approach to decipher host determinants for rotaviral infection (WB-DST): 2018-2021 ( 3 years)
  9. Cutting the host-aids: Studying mechanistic to host cellular determinants that are usurped by rotaviralviroplasmic proteins to design novel antiviral therapeutics (ICMR) :2020-2023 (3 Years)
  10. Screening and mechanistic study of small molecule inhibitors targeting host metabolism pathways as potential anti-rotaviral therapeutic agents.( DHR) 2021-2024 ( 3 years).
  11. ICMRs Centre for Product Development (ICMR) 2019-2024 ( 5 years)
  12. Identification of rotavirus induced dysregulated lncRNAs: An insight into the role of lncRNAs in regulating rotavirus infection. ( DST-SERB) 2022-2025 ( 3 years)
     

Intramural

  1. Development of a TaqMan-based multiplex qPCR assay for detection of common enteric parasites including Cryptosporidium spp( Co-PI) : 2024-2027 ( 3 years).
  2. A nano-herbal composite to target H pylori infection and associated gastric complications: a novel therapeutic approach ( Co-PI) : 2025-2028 ( 3 years).
     

Students presently working in the lab

JRF:

  • Doyel Biswas (UGC)
  • Swassata Kandar ( UGC)

SRF:

  • RitubritaSaha (UGC)
  • RanjanaSharma (CSIR)
  • Pritam Chandra (ICMR)SuvrotoaMitra ( DHR)

PDF

  • Dr Arpita Mukherjee (DHR)

 

Travel to foreign countries to attend conference/ meetings

  1. 16th Asian Conference on Diarrhoeal Disease and Nutrition (ASCODD 2022), Nov 11-13 2022 at The Westin, Kolkata. Invited lecture titled ?Rotavirus-NSP5 functions as a gatekeeper for Viroplasms: Selective access for host determinants?.
  2. International Conference on Evolution of Viruses and Viral Diseases ( VIROCON 2020), Feb 18-20, 2020 at Indian National Science Academy, New Delhi. Invited lecture titled ?Rotaviral Gastroenteritis: Current Scenario and future perspective towards alternative therapeutic approaches?
  3. Asian African Research Forum on Emerging and Reemerging Infections, Sept 5-6 2019 at Hokkaido University, Sapporo, Japan. Presentation title ?Andragrapholide exerts antagonistic effects on rotaviral infection: Therapeutic potential of an ethnomedicine adjunct to the conventional vaccination?
  4. 13th International Rotavirus Symposium at Minsk, Belarus during August 29-31, 2018. Presentation titled ?Genetic diversity of group a rotavirus strains in children hospitalized with gastroenteritis in West Bengal?.
  5. 20th International Conference of European Society of Clinical Virology. September 13th-16th 2017 at Stressa Convention Centre, Italy. Presentation Titled ?Rotavirus NSP4 triggers Drp1-dependent disruption of mitochondrial network which initiates intrinsic apoptotic cascade?.
  6. ?Japan India Bilateral Meeting on the collaborative research projects? and the ?International Seminar on Infectious Diseases? at the National Institute of Infectious Diseases (NIID), Tokyo during Jan 25th-27th 2015. Oral presentation on Rotavirus surveillance and ?Full genome characterization of unusual rotavirus group A genotypes G10P[14] and G12P[11] in hospitalized children with acute gastroenteritis in Kolkata, India?
  7. 17th International Conference on Emerging Infectious Diseases (EID) meeting at Taipei, Taiwan 25-29 Jan 2015. Oral presentation entitled ?Calmodulin Positively Regulates Rotavirus Infection by Modulating Host Cell Cycle Progression?.
  8. 17th International Conference on Emerging Infectious Diseases (EID) meeting at Taipei, Taiwan 25-29 Jan 2015. Oral presentation entitled ?Rotavirus modulates activity of antiviral protein Viperin to combat host induced IFN responses during infection?.
  9. Asian-African Research Forum on Emerging and Reemerging Infections, Sendai, Japan, 20-22 Jan 2014. Oral Presentation entitled ?Multiple functions of Rotavirus encoded Non-structural proteins (NSPs) for Combating host Responses during Infection?.
  10. 5th European Rotavirus biology Meeting Valencia, Spain, 6-9 October 2013. Oral presentation entitled ?Multiple Strategies adopted by Rotavirus encoded Non- structural protein (NSP1) for evasion of cellular responses?.
  11. 5th European Rotavirus biology Meeting Valencia, Spain, 6-9 October 2013. Poster presentation titled ?Community based case-control rotavirus surveillance study among children (< 5 yrs old) revealed coexistence of large number of Genotypes and increased prevalence of G9 strains in Kolkata.

Publications

2024

  1. Saha R, Lo M, De P, Deb AK, Indwar P, Miyoshi SI, Kitahara K, Oka T, Dutta S, Chawla-Sarkar M. Epidemiology of viral gastroenteritis in children and genetic diversity of rotavirus strains in Kolkata, West Bengal after introduction of rotavirus vaccine. Vaccine. 2024 Dec 27;45:126637.
  2. Mitra S, Datta Chaudhuri R, Sarkar R, Banerjee S, Mukherjee A, Sharma R, Gope A, Kitahara K, Miyoshi SI, Chawla-Sarkar M. Rotavirus rewires host cell metabolic pathways toward glutamine catabolism for effective virus infection. Gut Microbes. 2024 Jan-Dec;16(1):2428425
  3. Sharma SP, Chawla-Sarkar M, Sandhir R, Dutta D. Decoding the role of RNA sequences and their interactions in influenza A virus infection and adaptation. Wiley Interdiscip Rev RNA. 2024 Nov-Dec;15(6):e1871.
  4. Saha P, Saha R, Datta Chaudhuri R, Sarkar R, Sarkar M, Koley H, Chawla-Sarkar M. Unveiling the Antiviral Potential of Minocycline: Modulation of Nuclear Export of Viral Ribonuclear Proteins during Influenza Virus Infection. Viruses. 2024 Aug 18;16(8):1317.
  5. Mukherjee A, Lo M, Chandra P, Datta Chaudhuri R, De P, Dutta S, Chawla-Sarkar M. SARS-CoV-2 nucleocapsid protein promotes self-deacetylation by inducing HDAC6 to facilitate viral replication. Virol J. 2024 Aug 12;21(1):186..
  6. Chandra P, Patra U, Mukhopadhyay U, Mukherjee A, Halder P, Koley H, Chawla-Sarkar M. Rotavirus non-structural protein 4 usurps host cellular RIPK1-RIPK3 complex to induce MLKL-dependent necroptotic cell death. BiochimBiophysActaMol Cell Res. 2024 Jun;1871(5):119745.
  7. Lo M, Doan YH, Mitra S, Saha R, Miyoshi SI, Kitahara K, Dutta S, Oka T, Chawla Sarkar M. Comprehensive full genome analysis of norovirus strains from eastern India, 2017-2021. Gut Pathog. 2024 Jan 18;16(1):3.
  8. Banerjee S, Sarkar R, Mukherjee A, Mitra S, Gope A, Chawla-Sarkar M. Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection. Virus Res. 2024 Jan 2;339:199261..

2023

  1. Saha R, Majumdar A, Chaudhuri R D, Chatterjee A, Lo M , Dutta S, Chawla-Sarkar M. Molecular epidemiology of circulating human adenoviruses among acute respiratory infection patients seeking healthcare facilities in West Bengal India. Virology 2023 Nov;588:109912.
  2. Sarkar R, Patra U, Mukherjee A, Mitra S, Chawla-Sarkar M. Rotavirus circumvents the antiviral effects of protein ISGylation via proteasomal degradation of Ube1L. Cell Signal. 2023 Sep 16;112:110891.
  3. Indwar P, Roy R, Ganesh B, Choudhury S, Das S, Chawla-Sarkar M, Ganguly S. Neurological Manifestations in Rotavirus Gastroenteritis in Children Under two Years of Age. Indian Pediatr. 2023 Jun 15;60(6):495-496
  4. Majumdar A, Saha R, Chatterjee A, Gupta R, Chaudhuri RD, Chakrabarti AK, Chawla-Sarkar M, Dutta S. Upsurge in hospitalization of pediatric patients with severe acute respiratory infections in Kolkata and surrounding districts caused by recombinant human respiratory adenovirus type B 7/3. J Med Virol. 2023 Jul;95(7):e28897
  5. Banerjee A, Mazumder A, Roy J, Das J, Majumdar A, Chatterjee A, Biswas NK, Chawla Sarkar M, Das S, Dutta S, Maitra A. Emergence of a unique SARS-CoV-2 Delta sub-cluster harboring a constellation of co-appearing non-Spike mutations. J Med Virol. 2023 Jan;95(1):e28413

2022

  1. Sarkar R, Banerjee S, Halder P, Koley H, Komoto S, Chawla-Sarkar M. Suppression of classical nuclear import pathway by importazole and ivermectin inhibits rotavirus replication. J Antimicrob Chemother. 2022 Oct 10:dkac339.
  2. Chandra P, Banerjee S, Saha P, Chawla-Sarkar M, Patra U. Sneaking into the viral safe-houses: Implications of host components in regulating integrity and dynamics of rotaviral replication factories. Front Cell Infect Microbiol. 2022 Sep 14;12:977799.
  3. Mandeep Chadha, Aslesh Ottapura Prabhakaran, Manohar Lal Choudhary, Dipankar Biswas, Parvaiz Koul, K. Kaveri, Lalit Dar, Chawla Sarkar Mamta, Santosh Jadhav, Sumit Dutt Bhardwaj, Kayla Laserson, Siddhartha Saha, Varsha Potdar. PLOS Glob Pub Health.2022;2(11): e0001001.
  4. Banerjee S, Sarkar R, Mukherjee A, Miyoshi SI, Kitahara K, Halder P, Koley H, Chawla-Sarkar M. Quercetin, a flavonoid, combats rotavirus infection by deactivating rotavirus-induced pro-survival NF-κB pathway. Front Microbiol. 2022 Aug 2;13:951716.
  5. S Mitra, M Lo, R Saha, AK Deb, F Debnath, SI Miyoshi, S Dutta, M Chawla-Sarkar. Epidemiology of major entero-pathogenic viruses and genetic characterization of Group A rotaviruses among children (≤ 5 years) with acute gastroenteritis in eastern India. J Appl Microbiol. 2022 Aug;133(2):758-783.
  6. Mukhopadhyay U, Patra U, Chandra P, Saha P, Gope A, Dutta M, Chawla-Sarkar M. Rotavirus activates MLKL-mediated host cellular necroptosis concomitantly with apoptosis to facilitate dissemination of viral progeny. Mol Microbiol. 2022; 117:818-836. doi: 10.1111/mmi.14874.
  7. Sarkar R, Banerjee S, Mukherjee A, Chawla-Sarkar M. Rotaviral nonstructural protein 5 (NSP5) promotes proteasomal degradation of up-frameshift protein 1 (UPF1), a principal mediator of nonsense-mediated mRNA decay (NMD) pathway, to facilitate infection. Cell Signal. 2022 Jan; 89:110180. doi: 10.1016/j.cellsig.2021.110180.
  8. Sarkar R, Saha R, Mallick P, Sharma R, Kaur A, Dutta S, Chawla-Sarkar M. Emergence of a novel SARS-CoV-2 Pango lineage B.1.1.526 in West Bengal, India. J Infect Public Health. 2022 Jan;15(1):42-50. doi: 10.1016/j.jiph.2021.11.020.
  9. Banerjee A, Chawla-Sarkar M, Mukherjee A. Rotavirus-Mediated Suppression of miRNA-192 Family and miRNA-181a Activates Wnt/β-Catenin Signaling Pathway: An In Vitro Study. Viruses. 2022 Mar 9;14(3):558.

2021

  1. Sarkar R, Nandi S, Lo M, Gope A, Chawla-Sarkar M. Viperin, an IFN-Stimulated Protein, Delays Rotavirus Release by Inhibiting Non-Structural Protein 4 (NSP4)-Induced Intrinsic Apoptosis. Viruses. 2021; 13 (7):1324. Resource Link
  2. Malbari K, Saha P, Chawla-Sarkar M, Dutta S, Rai S, Joshi M, Kanyalkar M, In quest of small-molecules as potent non-competitive inhibitors against influenza,Bioorg Chem.2021 Sep;114. Resource Link
  3. Patra U, Mukhopadhyay U, Mukherjee A, Dutta S, Chawla-Sarkar M. Treading a HOSTile path: Mapping the dynamic landscape of host cell-rotavirus interactions to explore novel host-directed curative dimensions. Virulence. 2021; 12(1):1022-1062.
  4. Mukhopadhyay U, Banerjee A, Chawla-Sarkar M, Mukherjee A. Rotavirus Induces Epithelial-Mesenchymal Transition Markers by Transcriptional Suppression of miRNA-29b. Front Microbiol. 2021 12:631183.
  5. Sarkar R, Mitra S, Chandra P, Saha P, Banerjee A, Dutta S, Chawla-Sarkar M. Comprehensive analysis of genomic diversity of SARS-CoV-2 in different geographic regions of India: An endeavour to classify Indian SARS-CoV-2 strains on the basis of co-existing mutations. Arch Virol. 2021; 166(3):801-812.

2020

  1. Banerjee A, Sarkar R, Mitra S, Lo M, Dutta S, Chawla-Sarkar M. The novel coronavirus enigma: Phylogeny and analyses of coevolving mutations among the sars-cov-2 viruses circulating in India. JMIR Bioinformatics and Biotechnology. 2020;1(1):e20735.
  2. C.P. Girish Kumar, Giri S , Chawla-Sarkar M , Gopalkrishna V , Chitambar S D , Ray P, Venkatasubramanian S, Borkakoty B, Roy S , Bhat J , Dwibedi B , Paluru V , Das P , Arora R , Kang G , Mehendale S. M. , and National Rotavirus Surveillance Network investigators. Epidemiology of rotavirus diarrhea among children less than 5 years hospitalized with acute gastroenteritis prior to rotavirus vaccine introduction in India. Vaccine. 2020 3;38(51):8154-8160.
  3. Giri S, Girish Kumar CP, Khakha SA, Chawla-Sarkar M, Gopalkrishna V, Chitamber SD, Ray P, Venkatsubramaniam S, Borkakoty B, Roy S, Bhatt J, Dwibedi
  4. 7. Maitra A, Chawla Sarkar M, Raheja H , Biswas N. K., Singh A., Chakraborti S., Ghosh S., Sarkar S, Patra S, Mondal R. K, Ghosh T., Chatterjee A., Banu H, Majumdar A, Chinnaswamy S, Srinivasan N, Dutta S, S Das. Mutations in SARS-CoV-2 Viral RNA Identified in Eastern India: Possible Implications for the Ongoing Outbreak in India and Impact on Viral Structure and Host Susceptibility. Journal of Biosciences 2020; 45: 76.
  5. Das P, Palaru V, Ramani S, Babji S, Arora R, Mehendale SM, Gupte MD, Kang G. Diversity of rotavirus genotypes circulating in children < 5 years of age hospitalized for acute gastroenteritis in India from 2005 to 2016: analysis of temporal and regional genotype variation. BMC Infect Dis.;2020 Oct 9;20(1):740.
  6. Mitra S, Nayak MK, Majumdar A, Sinha A, Chatterjee S, Deb A, Chawla-Sarkar M, Dutta S. Development and evaluation of a multiplex conventional reverse-transcription polymerase chain reaction assay for detection of common viral pathogens causing acute gastroenteritis. Diagn Micr Infect Dis. 2020 Aug; 97(4):115061.
  7. Sarkar R, Patra U, Lo M, Mukherjee A, Biswas A, Chawla-Sarkar M. Rotavirus activates a noncanonical ATM-Chk2 branch of DNA damage response during infection to positively regulate viroplasm dynamics. Cell Microbiol. 2020 Mar; 22(3):e13149 . Pubmed

2019

  1. Nayak MK, Banerjee A, Sarkar R, Mitra S, Dutta K, Ganguly N, Ghosh C, Girish Kumar CP, Niyogi P, Panda S, Dutta S, Chawla-Sarkar M. Genetic characterization of group-A rotaviruses among children in eastern India during 2014-2016: Phylodynamics of co-circulating genotypes. Vaccine. 2019 Oct 23;37(45):6842-6856. Pubmed
  2. Mukhopadhyay U, Chanda S, Patra U, Mukherjee A, Komoto S, Chawla-Sarkar M. Biphasic regulation of RNA interference during rotavirus infection by modulation of Argonaute2. Cell Microbiol. 2019 Dec;21(12):e13101.   Pubmed
  3. Mukhopadhyay U, Chanda S, Patra U, Mukherjee A, Rana S, Mukherjee A, Chawla-Sarkar M. Synchronized Orchestration of miR-99b and let-7g Positively Regulates Rotavirus Infection by Modulating Autophagy.Sci Rep. 2019 Feb 4;9(1):1318.  Pubmed
  4. Patra U, Mukhopadhyay U, Sarkar R, Mukherjee A, Chawla-Sarkar M. RA-839, a selective agonist of Nrf2/ARE pathway, exerts potent anti-rotaviral efficacy in vitro.Antiviral Res. 2019 Jan;161:53-62.   Pubmed
  5. Rana S, Datta R, Chaudhuri RD, Chatterjee E, Chawla-Sarkar M, Sarkar S. Nanotized PPARα Overexpression Targeted to Hypertrophied Myocardium Improves Cardiac Function by Attenuating the p53-GSK3β-Mediated Mitochondrial Death Pathway.Antioxid Redox Signal. 2019 Feb 10;30(5):713-732.   Pubmed

2018

  1. Mukherjee A, Patra U, Bhowmick R, Chawla-Sarkar M. Rotaviral nonstructural protein 4 triggers dynamin-related protein 1-dependent mitochondrial fragmentation during infection. Cell Microbiol. 2018 Jun;20(6):e12831..
  2. Nayak MK,De P, Manna B, Dutta S, Bhadra UK, Chawla-Sarkar M. Species A rotaviruses isolated from hospitalized patients over 5 years of age in Kolkata, India, in 2012/13.Arch Virol. 2018 Mar;163(3):745-750.
  3. Banerjee A, Lo M, Indwar P, Deb AK, Das S, Manna B, Dutta S, Bhadra UK, Bhattacharya M, Okamoto K, Chawla-Sarkar M. Upsurge and spread of G3 rotaviruses in Eastern India (2014-2016): Full genome analyses reveals heterogeneity within Wa-like genomic constellation. Infect Genet Evol. 2018 May;63:158-174..

2017

  1. Doan YH, Suzuki Y, Fujii Y, Haga K, Fujimoto A, Takai-Todaka R, Someya Y, Nayak MK, Mukherjee A, Imamura D, Shinoda S, Chawla-Sarkar M, Katayama K. Complex reassortment events of unusual G9P[4] rotavirus strains in India between 2011 and 2013.Infect Genet Evol. 2017 Jul 25;54:417-428. . Pubmed
  2. Chattopadhyay S, Mukherjee A, Patra U, Bhowmick R, Basak T, Sengupta S, Chawla-Sarkar M. Tyrosine phosphorylation modulates mitochondrial chaperonin Hsp60 and delays rotavirus NSP4-mediated apoptotic signaling in host cells. Cell Microbiol. 2017 Mar;19(3). doi: 10.1111/cmi.12670.  Pubmed
  3. Banerjee A, De P, Manna B, Chawla-Sarkar M. Molecular characterization of enteric adenovirus genotypes 40 and 41 identified in children with acute gastroenteritis in Kolkata, India during 2013-2014. J Med Virol. 2017Sep 19; 89:606-614.   Pubmed
  4. Datta R, Bansal T, Rana S, Datta K, Datta Chaudhuri R, Chawla-Sarkar M, Sarkar S. Myocyte-Derived Hsp90 Modulates Collagen Upregulation via Biphasic Activation of STAT-3 in Fibroblasts during Cardiac Hypertrophy.Mol Cell Biol. 2017 Mar 1;37.  Pubmed

2016

  1. Mukherjee A, Nayak MK, Dutta S, Panda S, Satpathi BR, Chawla-Sarkar M. Genetic Characterization of Circulating 2015 A(H1N1)pdm09 Influenza Viruses from Eastern India. PLoS One. 2016 Dec 20;11:e0168464.  Pubmed
  2. Mandal P, Mullick S, Nayak MK, Mukherjee A, Ganguly N, Niyogi P, Panda S, Chawla-Sarkar M. Complete genotyping of unusual species A rotavirus G12P[11] and G10P[14] isolates and evidence of frequent in vivo reassortment among the rotaviruses detected in children with diarrhea in Kolkata, India, during 2014. Arch Virol. 2016 Jul 22;161:2773-2785.  Pubmed
  3. Chanda S, Nandi S, Chawla-Sarkar M. 2016. Rotavirus induced miR-142-5p elicits proviral milieu by targeting Non-canonical TGFβ signalling and apoptosis in cells. Cell Microbiol. 18(5):733-47 2015. Pubmed

2015

  1. Deb Chanda S, Banerjee A, Chakrabarti S. and Chawla Sarkar M. Cordecypin an Adenosine Analogue executes anti-RV effects by stimulating Induction of Type I Interferon. J Virol Antiviral Res. 2015 May 25;4:2.
  2. Shaheen M, M. Borysanyiova, M. Chawla Sarkar, N. EL-Esnawy. 2015. In vitro effect of Dodonaea viscose extracts on the replication of coxackivirus B3 and rotavirus. J Microbiol Antimicrob Agents 1(2): 47-50.
  3. Datta R, T. Bansal, S. Rana, K. Datta, S. Chattopadhyay, M. Chawla-Sarkar, S. Sarkar. 2015.Hsp90/Cdc37 assembly modulates TGFβ receptor-II to act as a profibrotic regulator of TGFβ signaling during cardiac hypertrophy. Cell Signal. 27(12):2410-24. Pubmed
  4. Sarkar T, S Das , A De , P Nandy, S Chattopadhyay , M. Chawla-Sarkar, A Nandy. 2015. H7N9 influenza outbreak in China 2013: In silico analyses of conserved segments of the hemagglutinin as a basis for the selection of peptide vaccine targets. Comput Biol Chem.59 Pt A:8-15. Pubmed
  5. Bhowmick R, A. Mukherjee, U. Patra , M.Chawla-Sarkar. 2015. Rotavirus disrupts cytoplasmic P bodies during infection. Virus Res. 210:344-54. Pubmed
  6. Chadha M.S, V.A Potdar, S. Saha, P..A. Koul, S. Broor, L. Dar, M. Chawla-Sarkar, D. Biswas, P. Gunasekaran, A. M. Abraham, S. Shrikhande, A.,Jain, B. Anukumar, R.B. Lal, A.C. Mishra. 2015.Dynamics of influenza seasonality at sub-regional levels in India and implications for vaccination timing.PLoS One. 10(5):e0124122. Pubmed
  7. Rana S., K. Datta, T.L. Reddy, E. Chatterjee, P. Sen, M. Pal-Bhadra, U. Bhadra, A. Pramanik, P. Pramanik, M. Chawla-Sarkar, S. Sarkar. 2015. A spatio-temporal cardiomyocyte targeted vector system for efficient delivery of therapeutic payloads to regress cardiac hypertrophy abating bystander effect. J Control Release. 200:167-78 Pubmed

2014

  1. Mullick S., A. Mukherjee , S. Ghosh , G.P. Pazhani, D. Sur , B. Manna , J. P. Nataro,M.M Levine , T. Ramamurthy , M.Chawla-Sarkar.2014 .Community based case-control study of rotavirus gastroenteritis among young children during 2008-2010 reveals vast genetic diversity and increased prevalence of G9 strains in Kolkata. PLoS One.9 (11):e112970. Pubmed
  2. Potdar V.A., M. R. Dakhave, P.B. Kulkarni, S.A. Tikhe, S. Broor, P. Gunashekaran, M. Chawla-Sarkar, A.Abraham, D. Biswas, K.N. Patil, A.A. Kadam, S.S. Kode, A.C. Mishra, M.S. Chadha. 2014. Antiviral drug profile of human influenza A B viruses circulating in India: 2004-2011. Indian J Med Res. 140(2):244-51. Pubmed
  3. Mullick S, P. Mandal, M.K. Nayak, S. Ghosh, P. De, K. Rajendran, M.K. Bhattacharya, U. Mitra, T. Ramamurthy, N. Kobayashi, M. Chawla-Sarkar. 2014. Hospital based surveillance and genetic characterization of rotavirus strains in children (5 years) with acute gastroenteritis in Kolkata, India, revealed resurgence of G9 and G2 genotypes during 2011-2013. Vaccine 32 Suppl 1:A20-28. Pubmed
  4. Bhowmick R, G. Banik, S. Chanda, S. Chattopadhyay, M.Chawla-Sarkar. 2014. Rotavirus infection induces G1 to S phase transition in MA104 cells via Ca+ 2;/Calmodulin pathway. Virology 454-455:270-279. Pubmed
  5. Nandi S, S. Chanda, P. Bagchi, M. K. Nayak., R. Bhowmick, M.Chawla-Sarkar 2014. MAVS protein is attenuated by rotavirus nonstructural protein 1. PLoS One. 18;9(3):e92126. Pubmed
  6. Panda S, A.K. Deb, M. Chawla-Sarkar, T. Ramamurthy, S. Ganguly, P. Pradhan, A. Chakraborty, S. Desai, M.D. Gupte, R. Dhere 2014. Factors associated with diarrhoea in young children and incidence of symptomatic rotavirus infection in rural West Bengal, India. Epidemiol Infect. 142:1848-1858. Pubmed
  7. Nayak MK, A.S Agrawal, S. Bose, S. Naskar, R. Bhowmick, S. Chakrabarti, S. Sarkar, M. Chawla-Sarkar. 2014. Antiviral activity of baicalin against influenza virus H1N1-pdm09 is due to modulation of NS1-mediated cellular innate immune responses. J Antimicrob Chemother. 69:1298-1310. Pubmed

2013

  1. Bagchi P, R Bhowmick, S Nandi, M Kant Nayak, M. Chawla-Sarkar.2013. Rotavirus NSP1 inhibits interferon induced non-canonical NF?B activation by interacting with TNF receptor associated factor 2. Virology 444: 41- 44 Pubmed
  2. Roy Mukherjee T, S Chanda, S Mullick, P De, M Dey-Sarkar, M.Chawla-Sarkar 2013. Spectrum of respiratory viruses circulating in eastern India: prospective surveillance among patients with influenza-like illness during 2010-2011. J Med Virol. 85: 1459-1465. Pubmed
  3. Mazumdar J, M Chawla-Sarkar, K Rajendran, A Ganguly, UK Sarkar, S,Ghosh, MD Sarkar, S. Maulik. Burden of respiratory tract infections among paediatric in and out-patient units during 2010-11. Eur Rev Med Pharmacol Sci. 17: 802-808. Pubmed
  4. Bhowmick R., U.C. Halder, S. Chattopadhyay, M.K. Nayak, M. Chawla-Sarkar. 2013. Rotavirus-Encoded Nonstructural Protein 1 Modulates Cellular Apoptotic Machinery by Targeting Tumor Suppressor Protein p53. J Virol. 87(12):6840-50. Pubmed
  5. Roy Mukherjee T., A. Mukherjee, S. Mullick, M. Chawla-Sarkar. 2013. Full genome analysis and characterization of influenza C virus identified in Eastern India. Infect Genet Evol. 16:419-25. Pubmed
  6. Chattopadhyay S, T. Basak, M.K. Nayak, G. Bhardwaj, A. Mukherjee, R. Bhowmick, S. Sengupta, O. Chakrabarti, N.S. Chatterjee, M. Chawla-Sarkar. 2013. Identification of Cellular Calcium Binding Protein Calmodulin as a Regulator of Rotavirus A Infection during Comparative Proteomic Study. PLoS One. 8(2):e56655. Pubmed
  7. Mukherjee A, S. Mullick, A.K. Deb, S. Panda, M. Chawla-Sarkar. 2013. First report of human rotavirus G8P[4] gastroenteritis in India: evidence of ruminants-to-human zoonotic transmission. J. Med. Virol. 85(3):537-45. Pubmed
  8. Bagchi P, S. Nandi, M.K Nayak, M. Chawla-Sarkar. 2013. Molecular Mechanism behind Rotavirus NSP1-Mediated PI3 Kinase Activation: Interaction between NSP1 and the p85 Subunit of PI3 Kinase. J Virol. 87(4):2358-2362. Pubmed
  9. Ghosh S, N. Urushibara, M. Chawla-Sarkar, T. Krishnan, N. Kobayashi. 2013. Whole genomic analyses of asymptomatic human G1P[6], G2P[6] and G3P[6] rotavirus strains reveal intergenogroup reassortment events and genome segments of artiodactyl origin. Infect Genet. Evol.. 16C: 165-173. Pubmed
  10. Mullick S, A. Mukherjee, S. Ghosh, G.P. Pazhani, D. Sur, B. Manna, J.P. Nataro, M.M. Levine, T. Ramamurthy, M. Chawla-Sarkar. 2013. Genomic analysis of human rotavirus strains G6P[14] and G11P[25] isolated from Kolkata in 2009 reveals interspecies transmission and complex reassortment events. Infect. Genet. Evol. 14:15-21. Pubmed

2012

  1. Roy Mukherjee T, A.S. Agrawal, S. Chakrabarti, M. Chawla-Sarkar. 2012. Full genomic analysis of an influenza A (H1N2) virus identified during 2009 pandemic in Eastern India: evidence of reassortment event between co-circulating A(H1N1)pdm09 and A/Brisbane/10/2007-like H3N2 strains. Virol J. 9: 233. Pubmed
  2. Mukherjee A, S. Mullick, N. Kobayashi, M. Chawla-Sarkar. 2012. The first identification of rare human group A rotavirus strain G3P[10] with severe infantile diarrhea in eastern India. Infect Genet Evol. 12: 1933-1937. Pubmed
  3. Bagchi P, S Nandi, S Chattopadhyay, R Bhowmick, UC Halder, MK Nayak, N Kobayashi, M Chawla-Sarkar.2012. Identification of common human host genes involved in pathogenesis of different rotavirus strains: an attempt to recognize probable antiviral targets.Virus Res. 169: 144-153. Pubmed
  4. Ghosh A, S. Chattopadhyay, M. Chawla-Sarkar, P. Nandy, A. Nandy. 2012. In silico study of rotavirus VP7 surface accessible conserved regions for antiviral drug/vaccine design. PLoS One.7: e40749 Pubmed
  5. Kahn G., S. Fitzwater, J. Tate, G. Kang, N. Ganguly, G. Nair, D. Steele, R. Arora, M. Chawla-Sarkar, U. Parashar, M. Santosham. 2012. Epidemiology and Prospects for Prevention of Rotavirus Disease in India. Indian Pediatr. 49: 467- 474. Pubmed
  6. Sarkar M., S. Chanda, S. Chakrabarti, J. Mazumdar, A. Ganguly, M.S.Chadha, A.C. Mishra, M. Chawla-Sarkar. 2012. Surveillance in Eastern India (2007-2009) revealed reassortment event involving NS and PB1-F2 gene segments among co-circulating
    influenza A subtypes. Virol J. 9: 3. Pubmed
  7. Mukherjee A., M.K. Nayak, T. Roy, S. Ghosh, T.N. Naik, N. Kobayashi, M. Chawla-Sarkar 2012. Detection of human G10 rotavirus strains with similarity to bovine and bovine-like equine strains from untypable samples. Infect Genet Evol. 12: 467- 470. Pubmed
  8. Chadha M.S., S. Broor, P. Gunasekaran, V.A. Potdar, A. Krishnan, M Chawla-Sarkar,
    D. Biswas, A.M. Abraham, S.V Jalgaonkar, H.,Kaur, A. Klimov, R.B Lal, A Moen, L. Kant,
    A.C Mishra. 2012. Multisite virological influenza surveillance in India: 2004-2008.
    Influenza Other Respi Viruses. 6: 196-203. Pubmed

2011

  1. Halder U.C, P. Bagchi, S.Chattopadhyay, D. Dutta, M. Chawla-Sarkar. 2011. Cell death regulation during influenza A virus infection by matrix (M1) protein: a model of
    viral control over the cellular survival pathway. Cell Death Dis. 2: e197. Pubmed
  2. Roy T., A.S Agrawal, A. Mukherjee, A.C Mishra, M.S. Chadha, H. Kaur, M.Chawla-Sarkar. 2011.Surveillance and molecular characterization of human influenza B viruses during 2006-2010 revealed co-circulation of Yamagata-like and Victoria-like strains in
    eastern India. Infect Genet Evol. 11:1595- 1601. Pubmed
  3. Koul P.A., M.A. Mir, N.K. Bali, M. Chawla-Sarkar, M. Sarkar, S. Kaushik, U.H. Khan, F Ahmad, R, Garten, R,B, Lal, S. Broor. 2011. Pandemic and seasonal influenza viruses among patients with acute respiratory illness in Kashmir (India). Influenza Other Respi Viruses. 5: e521-527. Pubmed
  4. Mukherjee A and Chawla-Sarkar M. Rotavirus Infection: A Perspective on Epidemiology, Genomic Diversity and Vaccine Strategies. 2011. Review, Indian J Virol, 22: 11-23.
  5. Ghosh A, Chawla-Sarkar M, Stuehr DJ. 2011 Hsp90 interacts with inducible NO synthase client protein in its heme-free state and then drives heme insertion by an ATP-dependent process. FASEB J. 25: 2049-2060. Pubmed
  6. Mukherjee A, Ghosh S, Bagchi P, Dutta D, Chattopadhyay S, Kobayashi N, Chawla-Sarkar M. Full genomic analyses of human G4P[4], G4P[6],G9P[19] and G10P[6] strains from North-eastern India: Evidence for interspecies transmission and complex reassortment events. 2011 Clin Microbiol Infect, 17: 1343-1346. Pubmed
  7. Sarkar M, A. S. Agrawal, R. Sharma Dey, S. Chattopadhyay, R. Mullick, P. De, S. Chakrabarti, M. Chawla-Sarkar. 2011. Molecular characterization and comparative analysis of pandemic H1N1/2009 strains with co-circulating seasonal H1N1/2009 strains from eastern India. Arch Virol. 156: 207-217. Pubmed
  8. Agrawal A. S, T. Roy, S. Ghosh, M. Chawla-Sarkar. 2011. Genetic variability of attachment (G) and Fusion (F) protein genes of human metapneumovirus strains circulating during 2006-2009 in Kolkata, Eastern India. Virol J. 8: 67. Pubmed
  9. Dey R. S, S. Ghosh, M. Chawla-Sarkar, S. Panchalingam, J. P. Nataro, D. Sur, B. Manna, T. Ramamurthy. 2011. Circulation of a novel pattern of infections by enteric adenovirus serotype 41 among children below 5 years of age in Kolkata, India. J Clin Microbiol. 49: 500-505. Pubmed
  10. Yamamoto D, S. Ghosh, M. Kuzuya, Y.H. Wang, X. Zhou, M. Chawla-Sarkar, S.K. Paul, M. Ishino, N. Kobayashi. 2011. Whole-genome characterization of human group C rotaviruses: identification of two lineages in the VP3 gene. J Gen Virol. 92:361-369. Pubmed

2010

  1. Mukherjee A, Roy T, Agrawal AS, Sarkar M, Dey R, Chakrabarti S, Chawla-Sarkar M. 2010 Prevalence and epidemiology of pandemic H1N1strains in hospitals of Eastern India. J Pub Health Epidemiol, 2: 171-174.
  2. Agrawal, A. S., M. Sarkar, S. Ghosh, T. Roy, S. Chakrabarti, R. Lal, A. C. Mishra, M. S. Chadha, M. Chawla-Sarkar. 2010. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India. Infect Genet Evol. 10: 1188-1198. Pubmed
  3. Chattopadhyay, S., P. Bagchi, D. Dutta, A. Mukherjee, N. Kobayashi, M. Chawla-Sarkar. 2010. Computational identification of post-translational modification sites and functional families reveal possible moonlighting role of rotaviral proteins. Bioinformation, 4(10): 448-451. Pubmed
  4. Bagchi P, D. Dutta, S. Chattopadhyay, A. Mukherjee, U.C. Halder, S. Sarkar, N. Kobayashi, S. Komoto, K. Taniguchi, M. Chawla-Sarkar 2010. Rotavirus Non-Structural Protein-1 suppresses virus induced cellular apoptosis to facilitate viral growth by activating the cell-survival pathways during early stages of infection. J Virol. 84:6834-6845. Pubmed
  5. Nagashima S, N. Kobayashi , S.K. Paul , S. Ghosh, M. Chawla-Sarkar, M.A Hossain, Krishnan T 2010. Identification of P[8]b subtype in OP354 like human rotavirus strains by a modified RT-PCR. Jpn J Infect Dis. 63:208-211. Pubmed
  6. Ghosh S, N. Kobayashi, S. Nagashima, M. Chawla-Sarkar, T. Krishnan, B. Ganesh , T. N. Naik. 2010. Full genome analysis and possible origin of a porcine G12 rotavirus strain RU172. Virus Genes. 40: 382-388. Pubmed
  7. Yamamoto D, S. Ghosh, B. Ganesh, T. Krishnan, M Chawla-Sarkar, M. M Alam, T.S. Aung, N. Kobayashi 2010. Analysis on Genetic Diversity and Molecular Evolution of Human Group B Rotaviruses Based on Whole Genome Segments. J Gen Virol. 91:1772-1781 Pubmed
  8. Mukherjee A, S. Chattopadhyay, P. Bagchi, D. Dutta, N.B. Singh, R. Arora, U.D. Parashar, J.R. Gentsch, M. Chawla-Sarkar 2010. Surveillance and molecular characterization of rotavirus strains circulating in Manipur, north-eastern India: increasing prevalence of emerging G12 strains. Infect Genet Evol. 10:311-20. Pubmed
  9. Ghosh S., N. Kobayashi, S. Nagashima, M. Chawla-Sarkar, T. Krishnan, B. Ganesh, T.N. Naik 2010. Molecular characterization of the VP1, VP2, VP4, VP6, NSP1 and NSP2 genes of bovine grop B rotaviruses: identification of a novel VP4 genotype. Arch Virol. 155:159-167. Pubmed

2009

  1. Agrawal A.S., M. Sarkar, S. Chakrabarti, K. Rajendran, H. Kaur, A.C. Mishra, M.K.Chatterjee, T.N. Naik, M.S. Chadha, M Chawla-Sarkar 2009. Comparitive evaluation of real time PCR and conventional RT-PCR during a 2 year surveillance for influenza and respiratory syncytial virus among children with acute respiratory infections in Kolkata, India reveals distinct seasonality of infection. J Med Microbiol. 58:1616-1622. Pubmed
  2. Chattopadhyay D, M. Chawla- Sarkar, T. Chatterjee, R. Sharma Dey, P. Bag, S.Chakraborti and M. T. Hassan Khan 2009. Recent advancements for the evaluation of antiviral activities of natural products. N. Biotechnol. 25:347-368. Review. Pubmed
  3. Dutta D., P. Bagchi, A. Chatterjee, M.K. Nayak, A. Mukherjee, S. Chattopadhyay, S. Nagashima, N. Kobayashi, S. Komoto , K. Taniguchi, M.Chawla-Sarkar 2009. The molecular chaperone heat shock protein-90 positively regulates rotavirus infection. Virology 391:325-333. Pubmed
  4. Nagashima S, N. Kobayashi, S.K.Paul, M.M. Alam, M Chawla-Sarkar, T. Krishnan 2009. Characterization of full-length VP4 genes of OP354-like P[8] human rotavirus strains detected in Bangladesh representing a novel P[8] subtype. Arch Virol. 154: 1223-1231. Pubmed
  5. Agrawal, A. S., M. Sarkar, S. Ghosh, M. Chawla Sarkar, N. Chakraborty, M. Basak, T. N. Naik. 2009. Prevalence of respiratory syncytial virus group B genotype BA-IV strains among children with acute respiratory tract infection in Kolkata, Eastern India. J Clin Virol. 45: 358-61. Pubmed
  6. Mukherjee, A., D. Dutta, S. Ghosh, P. Bagchi, S. Chattopadhyay, S. Nagashima, N. Kobayashi, P. Dutta, T. Krishnan, T. N. Naik, M. Chawla Sarkar. 2009. Full genomic analysis of a human group A rotavirus G9P[6] strain from Eastern India provides evidence for porcine-to-human interspecies transmission. Arch Virol. 154: 733-46. Pubmed

2008

  1. Samajdar, S., S. Ghosh, D. Dutta, M. Chawla Sarkar, N .Kobayashi, T. N. Naik. 2008. Human group A rotavirus P[8] Hun9-like and rare OP354 like strains are circulating among diarhoeic children in Eastern India. Arch Virol. 153: 1933-1936. Pubmed
  2. Samajdar, S., S. Ghosh, M. Chawla Sarkar, U. Mitra, P. Dutta, N. Kobayashi, T. N. Naik. 2008. Increase in prevalence of human group A rotavirus G9 strains as an important VP7 genotype among children in Eastern India. J. Clin. Virol. 43: 334-339. Pubmed
  3. Nagashima, S., N. Kobayashi, M. Ishino, M. M. Alam, M. U. Ahmed, S. K. Paul, B. Ganesh, M. Chawla Sarkar, T. Krishnan, T. N. Naik, Y. H. Wang. 2008. Whole genomic characterization of a human rotavirus strain B219 belonging to a novel group of the genus Rotavirus. J. Med. Virol. 80: 2023-2033. Pubmed
  4. Nayak, M. K., G. Balasubramanian, G. C. Sahoo, R. Bhattacharya, J. Vinje, N. Kobayashi, M. C. Sarkar, M. K. Bhattacharya, T. Krishnan. 2008. Detection of a novel intergenogroup recombinant Norovirus from Kolkata, India. Virology. 377: 117-23. Pubmed
  5. Alam, M. M., N. Kobayashi, M. Ishino, S. Nagashima, S. K. Paul, M. Chawla Sarkar, T. Krishnan, T. N. Naik. 2008. Identical rearrangement of NSP3 genes found in three independently isolated virus clones derived from mixed infection and multiple passages of Rotaviruses. Arch. Virol. 153: 555-559. Pubmed

2005

  1. Panda, K., M. Chawla Sarkar, C. Santos, T. Koeck, S. C. Erzurum, J. F. Parkinson and D. J. Stuehr. 2005. Visualizing inducible nitric-oxide synthase in living cells with a heme-binding fluorescent inhibitor. Proc. Natl. Acad. Sci. U S A. 102: 10117-10122. Pubmed
  2. Vaziri, S. A., J. Hill, K. Chikamuri, M. Chawla Sarkar, and R. Ganapathi. 2005. Sensitization of DNA damage induced apoptosis by proteosome inhibitor PS-341 is p53 dependent involves target proteins 14-33 sigma surviving. Mol. Cancer Ther. 4: 1880-1890. Pubmed

2004

  1. Sarkar S, Chawla-Sarkar M, Young D, Nishiyama K, Rayborn ME, Hollyfield JG, Sen S. Myocardial cell death and regeneration during progression of cardiac hypertrophy to heart failure. 2004 J Biol Chem. 279: 52630-52642. Pubmed
  2. Chawla Sarkar, M., S. Bae, F. J. Reu, B. S. Jacobs, D. J. Lindner and E. C. Borden. 2004. Down-regulation of Bcl-2, FLIP or IAPs (XIAP and survivin) by siRNAs sensitizes resistant melanoma cells to Apo2L/TRAIL-induced apoptosis. Cell Death and Differentiation. 11: 915-923. Pubmed

2003

  1. Chawla Sarkar, M., J. A. Bauer, J. A. Lupica, B. Morrison, Z. Tang, R. K. Oates, A. Almasan, J. A. DiDonato, E. C. Borden and D. J. Lindner. 2003. Suppression of NF-?appa B survival signaling by nitrosylcobalamin sensitizes neoplasms to the anti-tumor effects of Apo2L/TRAIL. J. Biol. Chem. 278: 39461-39469. Pubmed
  2. Leaman, D. W., M. Chawla Sarkar, K. Vyas, A. Ozdemir and E. C. Borden. 2003. Greater potency of IFN-beta compared to IFN-alpha2 in inducing interferon stimulated genes (ISGs) in Melanoma. Identification of new ISGs by oligonucleotide microarray. J. IFN. and Cytokine Res. 23: 745-756. Pubmed
  3. Chawla Sarkar, M., D. Lindner, Y. Liu, B. Williams, G. Sen, R. Silverman and E. C. Borden. 2003. Apoptosis and Interferons: Role of interferon -stimulated genes as mediators of apoptosis. (Review) Apoptosis, 8: 237-249. Pubmed

2002

  1. Chawla Sarkar, M., D. W. Leaman, B. S. Jacobs and E. C. Borden. 2002. IFN pretreatment sensitizes melanoma cells to tumor necrosis factor related apoptosis inducing ligand (TRAIL/Apo2L) induced apoptosis. J. Immunol. 169: 847-855. Pubmed
  2. Chawla Sarkar. M., D. W. Leaman, B. S. Jacobs, R. J. Tuthill, M. Chatterjee Kishore, G. Stark and E. C. Borden. 2002. Resistance to Interferons does not correlate with expression and activation of signal transducer and activator of transcription (STAT1) in melanoma cell lines. J. IFN. and Cytokine Res. 22: 603-613.
  3. Basu, A., M. Chawla Sarkar and S. K. DasGupta. 2002. The repA and repB domains of Mycobacterial plasmid pAL5000 replication region act synergistically to activate the formation of an origin complex. J. Bacteriol. 184: 2204-2214. Pubmed
  4. Leaman, D. W., M. Chawla Sarkar, K. Vyas, K. Tamai and E. C. Borden. 2002. Identification of X-linked inhibitor of apoptosis associated factor-1 (XAF1) as an IFN-stimulated proapoptotic gene. J. Biol. Chem. 277: 28504-28511. Pubmed
  5. Morrison, B. H., J. A. Bauer, J. Hu, R. W. Grane, A. M. Ozdemir, M. Chawla Sarkar, B. Gong, A. Almasan, D. V. Kalvakolanu and D. J. Lindner. 2002. Inositol hexakisphohate kinase 2 sensitizes ovarian carcinoma cells to multiple cancer therapeutics. Oncogene. 21: 1882-1889. Pubmed

2001

  1. Chawla Sarkar, M., D. W. Leaman and E. C. Borden. 2001. Preferential induction of apoptosis by IFN compared to IFN: Correlation with TRAIL/Apo2L induction in melanoma cell lines. Clinical Cancer Research. 7: 1821-1831. Pubmed

1999

  1. Chawla, M., and S. K. DasGupta. 1999. Transposition induced structural instability of E.coli - mycobacteria shuttle vectors. Plasmid. 41: 135-140. Pubmed

Scientific Reviews

  1. Mukherjee A, Chatopadhyay S, Chawla-Sarkar M. Rotavirus Infection in India: A Major Cause of Childhood Gastroenteritis. Proc National Acad Sci, India Section B: Biol Sci. 2012 Mar 1;82(1):135-51.
  2. Kahn G, Fitzwater S, Tate J, Kang G, Ganguly N, Nair G, Steele D, Arora R, Chawla Sarkar M, Parashar U, Santosham M. Epidemiology and prospects for prevention of rotavirus disease in India. Indian Pediatr. 2012 Jun 1;49(6):467-74.  Pubmed
  3. Mukherjee A, Chawla-Sarkar M. Rotavirus infection: a perspective on epidemiology, genomic diversity and vaccine strategies. Indian J Virol. 2011 Jun 1;22(1):11-23 Pubmed
  4. Chattopadhyay D, Chawla-Sarkar M, Chatterjee T, Dey RS, Bag P, Chakraborti S, Khan MT. Recent advancements for the evaluation of anti-viral activities of natural products. New Biotechnol 2009 Jun 30;25(5):347-68.  Pubmed
  5. Chawla-Sarkar M, Lindner DJ, Liu YF, Williams BR, Sen GC, Silverman RH, Borden EC. Apoptosis and interferons: role of interferon-stimulated genes as mediators of apoptosis. Apoptosis 2003 Jun 1;8(3):237-49.   Pubmed

Book Chapters

  1. Kobayashi N, Ishino M, Wang YH, Chawla-Sarkar M, Krishnan T, Naik TN. Diversity of G-type and P-type of human and animal rotaviruses and its genetic background. Communicating Curr Res Educ Top Trends ApplMicrobiol. 2007:847-58..
  2. Chawla-Sarkar M., P. Masci and E C Borden.Interferons for cancer therapy: Key contributions of recombinant biotechnology,InEd Rodney, J. Y. Ho and M. Gibaldi (ed.), Biotechnology & Biopharmaceuticals: Transforming Proteins and Genes into Drugs. J Wiley & Sons Inc., New Jersey, USA. 2003: p. 161-179.